Analyst Reco. Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
5.96 ^USD	+6.24%		+12.88%	+15.50%

05-03	Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed	MT
05-02	Earnings Flash (SGHT) SIGHT SCIENCES Reports Q1 Revenue $19.3M, vs. Street Est of $18.4M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Adjusts Price Target on Sight Sciences to $7 From $6, Keeps Buy Rating	03-08	MT
Morgan Stanley Adjusts Sight Sciences Price Target to $4 From $3, Maintains Equal Weight Rating	12-04	MT
Stifel Adjusts Price Target on Sight Sciences to $5 From $11, Maintains Buy Rating	23-09-18	MT
Citigroup Trims Price Target on Sight Sciences to $4 From $8, Maintains Neutral Rating	23-09-15	MT
Morgan Stanley Trims Price Target on Sight Sciences to $4 From $8.40, Maintains Equalweight Rating	23-09-13	MT
BofA Securities Downgrades Sight Sciences to Underperform From Neutral, Adjusts Price Target to $4.50 From $10	23-09-12	MT
William Blair Downgrades Sight Sciences to Market Perform From Outperform	23-09-12	MT
Piper Sandler Downgrades Sight Sciences to Neutral From Overweight, Adjusts Price Target to $5.50 From $15	23-09-12	MT
Morgan Stanley Downgrades Sight Sciences to Equalweight From Overweight, Adjusts Price Target to $8.40 From $12	23-08-24	MT
Citigroup Trims Sight Sciences Price Target to $8 From $9, Maintains Neutral Rating	23-08-21	MT
Citigroup Downgrades Sight Sciences to Neutral From Buy, Adjusts Price Target to $9 From $15	23-07-11	MT
Citigroup Downgrades Sight Sciences to Neutral From Buy, Lowers Price Target to $9 From $15	23-07-10	MT
Stifel Adjusts Price Target on Sight Sciences to $13 From $15, Maintains Buy Rating	23-06-26	MT
BofA Securities Adjusts Sight Sciences Price Target to $10 From $13, Maintains Buy Rating	23-06-06	MT
Morgan Stanley Adjusts Sight Sciences' Price Target to $15 From $11, Keeps Overweight Rating	23-01-06	MT
Stifel Nicolaus Upgrades Sight Sciences to Buy From Hold, Adjusts Price Target to $15 From $10	23-01-06	MT
Citigroup Adjusts Price Target on Sight Sciences to $15 From $10, Maintains Buy Rating	22-12-12	MT
Morgan Stanley Adjusts Sight Sciences' Price Target to $10 from $14, Maintains Overweight Rating	22-10-11	MT
Needham Initiates Sight Sciences at Hold, Says While Dry Eye Business Potentially 'Significant Revenue Growth Driver,' Market Development Likely 'to Take Time, Further Investment'	22-10-04	MT
Morgan Stanley Adjusts Price Target on Sight Sciences to $14 From $17, Reiterates Overweight Rating	22-08-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Analyst Reco.

Filters